Avid Bioservices Inc (CDMO)

[patientsdeservebest]

it is easily argued there are no damages.
1) as many here have said the FDA approved Phase III so the alleged mixup didn't stop that
2) it is likely that PPHM botched the vial situation. It is a matter of record that PPHM wanted the A B and C groups to be placebo, 1 mg/kg and 3 mg/kg. Guess what, the whole purpose of a double blind study is that nobody knows what is being given. It was perfectly correct for CSM to label anyway they saw fit. Only PPHM assumed that A B and C were what they wanted. and as they cooked up the data and the censored patients before the unblinding they never figured out that the worst outcome was 1 mg/kg and that the placebo and the 3 mg/kg were nearly identical in MOS.

bottom line- PPHM does not understand what a double blind study is.